Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537004 · ClinicalTrials.gov registry record
Language in Primary Progressive Aphasia
A clinical trial of Primary Progressive Aphasia, sponsored by Northwestern University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT00537004 is a study of Primary Progressive Aphasia that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 500 participants, above the 59-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (747% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00537004, a study of Primary Progressive Aphasia, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to further define the neurological and linguistic deterioration in primary progressive aphasia.
Conditions Studied
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2007-05 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00537004
The ClinicalTrials.gov registry entry for NCT00537004 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 59-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (747% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Progressive Aphasia appearing as the primary indexed condition, and to 0 interventions.
NCT00537004 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00537004 about?
NCT00537004 is a clinical study titled "Language in Primary Progressive Aphasia". The purpose of this study is to further define the neurological and linguistic deterioration in primary progressive aphasia.
What is the current status of trial NCT00537004?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2007-05. Estimated completion is 2027-04.
What conditions does trial NCT00537004 study?
This clinical trial studies the following conditions: Primary Progressive Aphasia.
Who is sponsoring clinical trial NCT00537004?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00537004 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Progressive Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
RECRUITING · Phase 4
-
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
RECRUITING
-
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
RECRUITING · Phase 2
-
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
RECRUITING · Early Phase 1
-
Enhancing Language Function in Aphasia
RECRUITING · NA
-
Enhancing Language Function in Primary Progressive Aphasia
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.